Alexey Vinogradov
Director/Board Member at XENETIC BIOSCIENCES, INC.
Net worth: 72 848 $ as of 2024-05-30
Alexey Vinogradov active positions
| Companies | Position | Start | End |
|---|---|---|---|
| XENETIC BIOSCIENCES, INC. | Director/Board Member | 2019-07-18 | - |
| Independent Dir/Board Member | 2019-07-18 | - | |
| PHARMSYNTHEZ | Director/Board Member | 2023-08-02 | - |
Avelas Biosciences, Inc.
 Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | Director/Board Member | 2017-03-13 | - |
| Cantreva LLC | Chief Operating Officer | 2017-08-31 | - |
Career history of Alexey Vinogradov
Former positions of Alexey Vinogradov
| Companies | Position | Start | End |
|---|---|---|---|
| Togas Middle East LLC | Corporate Officer/Principal | 2015-04-30 | 2017-04-30 |
| Togas Group LLC | Corporate Officer/Principal | 2012-02-29 | 2016-10-31 |
| ARGOS THERAPEUTICS, INC. | Director/Board Member | 2014-02-05 | 2016-06-09 |
| Independent Dir/Board Member | 2014-02-05 | 2016-06-09 | |
Bioprocess Capital Partners Ltd.
 Bioprocess Capital Partners Ltd. Investment ManagersFinance Bioprocess Capital Partners Ltd (BCP) is a venture capital firm founded in 2006. The firm is headquartered in Moscow, Russia. | Private Equity Investor | 2010-12-30 | 2010-12-30 |
Pharmstandard Ventures
 Pharmstandard Ventures Investment ManagersFinance Pharmstandard Ventures (Pharmstd Ventures) is a venture capital subsidiary of Pharmstandard PJSC headquartered in Moscow, Russia. The firm was founded in 2013 by Dr. Andrey Petrov. | Chief Executive Officer | 2011-12-31 | - |
| Corporate Officer/Principal | 2011-12-31 | - |
Training of Alexey Vinogradov
| Moscow State University Lomonosov | Doctorate Degree |
Statistics
International
| Russia | 7 |
| United States | 4 |
| United Arab Emirates | 2 |
Operational
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Independent Dir/Board Member | 2 |
Sectoral
| Health Technology | 4 |
| Finance | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| PHARMSYNTHEZ | Health Technology |
| XENETIC BIOSCIENCES, INC. | Health Technology |
| Private companies | 7 |
|---|---|
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
Bioprocess Capital Partners Ltd.
Bioprocess Capital Partners Ltd. Investment ManagersFinance Bioprocess Capital Partners Ltd (BCP) is a venture capital firm founded in 2006. The firm is headquartered in Moscow, Russia. | Finance |
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | Health Services |
Pharmstandard Ventures
Pharmstandard Ventures Investment ManagersFinance Pharmstandard Ventures (Pharmstd Ventures) is a venture capital subsidiary of Pharmstandard PJSC headquartered in Moscow, Russia. The firm was founded in 2013 by Dr. Andrey Petrov. | Finance |
| Cantreva LLC | |
| Togas Middle East LLC | |
| Togas Group LLC |
- Stock Market
- Insiders
- Alexey Vinogradov
- Experience
